A prominent example is DNA methylation within CpG islands of the KEAP1 promoter, which is frequently hypermethylated in various cancers, resulting in suppressed KEAP1 expression and the aberrant activation of Nrf2 [25]. The gene discussed is KEAP1; the disease is cancer.